Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Navigating Cellular Gateways Drug Transporters and Therapeutic Delivery

Mohsen Haidary

The effective delivery of therapeutic agents to their target sites within the human body is a complex endeavor that relies on a myriad of intricate processes. Central to this challenge are the cellular gateways, specialized membrane transport proteins that regulate the movement of molecules across cell membranes. These gatekeepers, known as drug transporters, play a pivotal role in modulating the absorption, distribution, and excretion of drugs and other molecules. As such, understanding the functioning and regulation of drug transporters is paramount for optimizing therapeutic delivery strategies and enhancing drug efficacy. As the field continues to evolve, researchers are uncovering novel strategies to exploit drug transporters for targeted drug delivery and enhanced therapeutic outcomes. We discuss current approaches that leverage transporter-mediated drug delivery systems, including prodrugs, nanoparticles, and carrier-mediated transport.